| Authors: |
Davies CR; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Guo T; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Cell Biology and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Burke E; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Stankiewicz E; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Central Biobank, Medical University of Gdansk, Gdansk, Poland., Xu L; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China., Mao X; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Scandura G; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Rajan P; Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Urology, Barts Health National Health Service Trust (NHS), London, United Kingdom.; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; University College London Hospitals, National Health Service (NHS) Foundation Trust, London, United Kingdom., Tipples K; Department of Urology, Barts Health National Health Service Trust (NHS), London, United Kingdom., Alifrangis C; University College London Hospitals, National Health Service (NHS) Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Barts Health National Health Service (NHS) Trust, London, United Kingdom., Wimalasingham AG; Department of Medical Oncology, Barts Health National Health Service (NHS) Trust, London, United Kingdom., Galazi M; Department of Medical Oncology, Barts Health National Health Service (NHS) Trust, London, United Kingdom., Crusz S; Department of Medical Oncology, Barts Health National Health Service (NHS) Trust, London, United Kingdom., Powles T; Department of Urology, Barts Health National Health Service Trust (NHS), London, United Kingdom.; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Grey A; Department of Urology, Barts Health National Health Service Trust (NHS), London, United Kingdom.; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; University College London Hospitals, National Health Service (NHS) Foundation Trust, London, United Kingdom., Oliver T; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Kudahetti S; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Shaw G; Department of Urology, Barts Health National Health Service Trust (NHS), London, United Kingdom.; Division of Surgery and Interventional Sciences, University College London, London, United Kingdom.; University College London Hospitals, National Health Service (NHS) Foundation Trust, London, United Kingdom., Berney D; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Shamash J; Department of Medical Oncology, Barts Health National Health Service (NHS) Trust, London, United Kingdom., Lu YJ; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. |
